APPLICATION
BLA761211
TYPE
BLA
ORIGINAL APPROVAL
2026-02-23
LATEST ACTION
2026-02-23
ROUTE
INTRAVENOUS, SUBCUTANEOUS, Injection
DOSAGE FORM
Injectable
MARKETING STATUS
Prescription
Products
LOARGYSPrescription
PEGZILARGINASE-NBLN 0.1MG/KG · Injectable · Injection
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.